# Kadmon I LLC — Form D

Kadmon I LLC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-22. The offering totals $50.0M, of which $10.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-07-22
- Form: D
- Accession: 0001497178-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $50.0M
- Amount sold: $10.8M
- Remaining: $39.2M
- Minimum investment: $100K
- Investors: 26
- Date of first sale: 2010-07-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-145358

## Issuer

- Name: Kadmon I LLC
- CIK: 0001497178
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 400 MADISON AVE, NEW YORK, NY, 10017
- Phone: 212-608-3000

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Samuel D Waksal | Director | New York, NY |
| Steven N Gordon | Executive Officer | New York, NY |
| Samuel D Waksal | Executive Officer | New York, NY |

## More

- [CIK 1497178 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1497178&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001497178-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.